
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 33.9% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 33.6% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 31.4% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 27.5% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 11.6% according to JP Morgan.JP Morgan set a target price of 323 GBX for the company, which when..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 13.7% according to JP Morgan.JP Morgan set a target price of 323 GBX for the company, which when..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 28.4% according to Berenberg Bank.Berenberg Bank set a target price of 290 GBX for the company, which when..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 36.5% according to RBC Capital Markets.RBC Capital Markets set a target price of 300 GBX for the company,..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 35.4% according to RBC Capital Markets.RBC Capital Markets set a target price of 300 GBX for the company,..
ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 33.3% according to Barclays.Barclays set a target price of 310 GBX for the company, which when compared to..
Convatec Group plc (LON:CTEC), a global medical products and technologies company, has announced a trading update for the four months ended 30 April 2023. Revenue increased by 3.1% on an..
Convatec Group Plc [LON:CTEC] has announced it has acquired the anti-infective nitric oxide technology platform of 30 Technology Limited which includes new product assets and research and development. In addition..

















































